14-Year Risk of All-Cause Mortality According to Hypoglycaemic Drug Exposure in a General Population

Emilie Bérard; Vanina Bongard; Jean Dallongeville; Dominique Arveiler; Dominique Cottel; Aline Wagner; Jean-Bernard Ruidavets; Jean Ferrières

doi:10.1371/journal.pone.0095671

Loading metrics

Open Access

Peer-reviewed

Research Article

14-Year Risk of All-Cause Mortality According to Hypoglycaemic Drug Exposure in a General Population

Emilie Bérard,

Affiliation Department of Epidemiology, Health Economics and Public Health, UMR-1027 INSERM, Toulouse University School of Medicine, Toulouse University Hospital, Toulouse, France
⨯
Vanina Bongard,

Affiliation Department of Epidemiology, Health Economics and Public Health, UMR-1027 INSERM, Toulouse University School of Medicine, Toulouse University Hospital, Toulouse, France
⨯
Jean Dallongeville,

Affiliation Department of Epidemiology and Public Health, U-744 INSERM, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France
⨯
Dominique Arveiler,

Affiliation Department of Epidemiology and Public Health, EA 3430, Université de Strasbourg, Faculté de Médecine, Strasbourg, France
⨯
Dominique Cottel,

Affiliation Department of Epidemiology and Public Health, U-744 INSERM, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France
⨯
Aline Wagner,

Affiliation Department of Epidemiology and Public Health, EA 3430, Université de Strasbourg, Faculté de Médecine, Strasbourg, France
⨯
Jean-Bernard Ruidavets,

Affiliation Department of Epidemiology, Health Economics and Public Health, UMR-1027 INSERM, Toulouse University School of Medicine, Toulouse University Hospital, Toulouse, France
⨯
Jean Ferrières

* E-mail: jean.ferrieres@univ-tlse3.fr

Affiliations Department of Epidemiology, Health Economics and Public Health, UMR-1027 INSERM, Toulouse University School of Medicine, Toulouse University Hospital, Toulouse, France, Department of Cardiology B, Toulouse University Hospital, Toulouse, France
⨯

14-Year Risk of All-Cause Mortality According to Hypoglycaemic Drug Exposure in a General Population

Emilie Bérard,
Vanina Bongard,
Jean Dallongeville,
Dominique Arveiler,
Dominique Cottel,
Aline Wagner,
Jean-Bernard Ruidavets,
Jean Ferrières

Published: April 21, 2014
https://doi.org/10.1371/journal.pone.0095671

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Type 2 diabetes
Is the Subject Area "Type 2 diabetes" applicable to this article?

Thanks for your feedback.
Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Cholesterol
Is the Subject Area "Cholesterol" applicable to this article?

Thanks for your feedback.
Type 2 diabetes risk
Is the Subject Area "Type 2 diabetes risk" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.
Physical activity
Is the Subject Area "Physical activity" applicable to this article?

Thanks for your feedback.